| Stage | ROK | % of rev | TMO | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.3B | 100.00% | $12.1B | 100.00% | TMO ×5.25 |
| Gross profit | $1.1B | 49.46% | $5.1B | 42.28% | ROK +7.2pp |
| Operating income | $481M | 20.80% | $2.3B | 18.65% | ROK +2.2pp |
| Pre-tax income | $470M | 20.32% | $2.1B | 17.20% | ROK +3.1pp |
| Net income | $408M | 17.64% | $1.7B | 14.23% | ROK +3.4pp |
| Stage | ROK | TMO | Gap · A − B |
|---|---|---|---|
| Revenue | $2.3B100.00% | $12.1B100.00% | TMO ×5.25 |
| Gross profit | 49.46%$1.1B | 42.28%$5.1B | ROK +7.2pp |
| Operating income | 20.80%$481M | 18.65%$2.3B | ROK +2.2pp |
| Pre-tax income | 20.32%$470M | 17.20%$2.1B | ROK +3.1pp |
| Net income |
| 17.64%$408M |
| 14.23%$1.7B |
| ROK +3.4pp |
No shared counterparties.